Join Now

Author Archives: Natalie Themm

Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease

By Natalie Themm | Published July 29, 2025

Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease

Posted in BioUtah News | Tagged | Comments Off on Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease

Improving Women’s Health: MobileODT Joins Liger Medical

By Natalie Themm | Published July 24, 2025

Improving Women’s Health: MobileODT Joins Liger Medical

Posted in BioUtah News | Tagged | Comments Off on Improving Women’s Health: MobileODT Joins Liger Medical

Wasatch Health Announces Structured Capital Fund

By Natalie Themm | Published July 24, 2025

Utah Investment Firm Expands to Deliver Flexible Capital to Transformative Healthcare Companies

Posted in BioUtah News | Tagged | Comments Off on Wasatch Health Announces Structured Capital Fund

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

By Natalie Themm | Published July 23, 2025

Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

Posted in BioUtah News | Tagged | Comments Off on Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

By Natalie Themm | Published July 23, 2025

Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

Posted in BioUtah News | Tagged | Comments Off on Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

By Natalie Themm | Published July 17, 2025

Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

Posted in BioUtah News | Tagged | Comments Off on Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

By Natalie Themm | Published July 10, 2025

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

Posted in BioUtah News | Tagged | Comments Off on BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform

By Natalie Themm | Published July 10, 2025

Canary Speech announces it has obtained HITRUST e1 Certification, reinforcing its commitment to cybersecurity related to its voice biomarker technology.

Posted in BioUtah News | Tagged | Comments Off on Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

By Natalie Themm | Published July 10, 2025

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Posted in BioUtah News | Tagged | Comments Off on Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

By Natalie Themm | Published July 10, 2025

FDA assigns PDUFA target action date of January 5, 2026, for decision on accelerated approval.

Posted in Policy News | Tagged | Comments Off on Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

GE HealthCare’s Economic Impact Across Utah

By Natalie Themm | Published July 10, 2025

GE HealthCare’s Economic Impact Across Utah

Posted in BioUtah News | Tagged | Comments Off on GE HealthCare’s Economic Impact Across Utah

RefloDx Wins Trans Atlantic Angel Grand Prize

By Natalie Themm | Published July 10, 2025

RefloDx Wins Trans Atlantic Angel Grand Prize.

Posted in BioUtah News | Tagged | Comments Off on RefloDx Wins Trans Atlantic Angel Grand Prize

A Special Thanks To Our Legacy and Platinum Elite Members